These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Levels in plasma of the serine proteases and associated proteins of the lectin pathway are altered in patients with systemic lupus erythematosus. Troldborg A, Thiel S, Laska MJ, Deleuran B, Jensenius JC, Stengaard-Pedersen K. J Rheumatol; 2015 Jun; 42(6):948-51. PubMed ID: 25877499 [Abstract] [Full Text] [Related]
26. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis. Colliard S, Jourde-Chiche N, Clavarino G, Sarrot-Reynauld F, Gout E, Deroux A, Fougere M, Bardin N, Bouillet L, Cesbron JY, Thielens NM, Dumestre-Pérard C. Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037 [Abstract] [Full Text] [Related]
29. Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication. Matsushita M, Endo Y, Fujita T. Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):273-83. PubMed ID: 23563865 [Abstract] [Full Text] [Related]
31. Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways. Ceribelli A, Andreoli L, Cavazzana I, Franceschini F, Radice A, Rimoldi L, Sinico RA, Carlsson M, Wieslander J, Tincani A. Ann N Y Acad Sci; 2009 Sep; 1173():427-34. PubMed ID: 19758182 [Abstract] [Full Text] [Related]
33. Purification, measurement of concentration, and functional complement assay of human ficolins. Matsushita M, Kilpatrick D, Shiraki H, Liu Y, Tateishi K, Tsujimura M, Endo Y, Fujita T. Methods Mol Biol; 2014 Sep; 1100():141-59. PubMed ID: 24218257 [Abstract] [Full Text] [Related]
34. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies. Hasan SI, Mohd Ashari NS, Mohd Daud K, Che Husin CM. Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264 [Abstract] [Full Text] [Related]
35. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis. Du Y, Wu X, Chen M, Wang W, Xv W, Ye L, Wu D, Xue J, Sun W, Luo J, Wu H. Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160 [Abstract] [Full Text] [Related]
38. The potential role of the lectin pathway of complement in the host defence of full-term intrauterine growth restricted neonates at birth. Briana DD, Liosi S, Gourgiotis D, Boutsikou M, Baka S, Marmarinos A, Hassiakos D, Malamitsi-Puchner A. J Matern Fetal Neonatal Med; 2012 May; 25(5):531-4. PubMed ID: 22082351 [Abstract] [Full Text] [Related]
39. Clinical and immunogenetic factors associated with pneumonia in patients with systemic lupus erythematosus: a case-control study. Rúa-Figueroa I, Nóvoa J, García-Laorden MI, Erausquin C, García-Bello M, Rodríguez de Castro F, Herrera-Ramos E, Ojeda S, Quevedo JC, Francisco F, Naranjo A, Rodríguez-Lozano C, Rodríguez-Gallego C. J Rheumatol; 2014 Sep; 41(9):1801-7. PubMed ID: 25086072 [Abstract] [Full Text] [Related]